Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin, Pemetrexed and Bevacizumab in Untreated Malignant Mesothelioma
NCT00295503Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Feb 2006
- Primary completion
- Jun 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in malignant mesothelioma, sponsored by UT Southwestern Medical Center. Started Feb 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
malignant mesothelioma
Beyond the preview
Go deeper on NCT00295503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00295503.